Krithika Muthyala
Hematology & Oncology · Mobile, ALNPI 1831849223
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in AL, where the typical reported total is $7,159.
Across 44 payments — averaging $24.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$147
- Incyte Corporation$114
- Caris MPI, Inc.$108
- Novartis$89
- Regeneron Healthcare Solutions, Inc.$75
- Merck$67
- plus $456 from 16 others
What the payments were for
- Food & beverage$1,056100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 7 | $147 |
| Incyte Corporation | 6 | $114 |
| Caris MPI, Inc. | 1 | $108 |
| Novartis | 4 | $89 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| Merck | 3 | $67 |
| Actelion Pharmaceuticals US, Inc. | 2 | $56 |
| Genentech USA, Inc. | 2 | $52 |
| Array Biopharma Inc | 2 | $46 |
| Johnson & Johnson | 2 | $42 |
| Beone Medicines USA, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Syndax Pharmaceuticals, Inc. | 1 | $25 |
| United Therapeutics Corporation | 1 | $24 |
| Pharmaessentia USA Corporation | 1 | $23 |
| Invivyd Inc | 1 | $21 |
| Recordati_rare_diseases_inc. | 1 | $21 |
| GSK | 1 | $20 |
| Shionogi Inc | 1 | $20 |
| Sanofi | 1 | $19 |
| Corcept Therapeutics | 1 | $17 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MI CANCER SEEK$108
How this compares
$1,056 in reported general payments places this provider in the 20th percentile of 177 hematology & oncology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 24 | $163 |
| Amlodipine Besylate | 16 | $63 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Mobile
- Anita MazloomMobile$20K
- Sherri ArledgeMobile$19K
- Daniel CameronMobile$17K
- Jose Galeas SorianoMobile$17K
- Michael MeshadMobile$14K
- Amitkumar MehtaBirmingham$683K
- Pankit VachhaniBirmingham$545K
- Luciano CostaBirmingham$409K
- Khaleel AshrafBirmingham$379K
- Michael BirrerBirmingham$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.